Health and Fitness Health and Fitness
Wed, January 30, 2013
[ Wed, Jan 30th 2013 ] - Market Wire
BacTech Signs MOU with COMIBOL
[ Wed, Jan 30th 2013 ] - Market Wire
DHS Holding, Co. Plans Move
[ Wed, Jan 30th 2013 ] - Market Wire
Mining for Health

PDL BioPharma Announces Departure of Finance VP


Published on 2013-01-30 04:01:03 - Market Wire
  Print publication without navigation


PDL BioPharma Announces Departure of Finance VP -- INCLINE VILLAGE, Nev., Jan. 30, 2013 /PRNewswire/ --

INCLINE VILLAGE, Nev., Jan. 30, 2013 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: [ PDLI ]) today announced that Caroline Krumel resigned her position as vice president of finance and principal accounting officer effective immediately on January 25th. Ms. Krumel did not advise the Company of any disagreements over any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure. The company will begin a search for a new Finance VP.

(Logo:  [ http://photos.prnewswire.com/prnh/20110822/SF55808LOGO ])

About PDL BioPharma
PDL pioneered the humanization of monoclonal antibodies and, by doing so, enabled the discovery of a new generation of targeted treatments for cancer and immunologic diseases. Today, PDL is focused on intellectual property asset management, investing in new revenue generating assets and maximizing value for its shareholders. For more information, please visit [ www.pdl.com ].

NOTE: PDL BioPharma and the PDL BioPharma logo are considered trademarks of PDL BioPharma, Inc.

SOURCE PDL BioPharma, Inc.



RELATED LINKS
[ http://www.pdl.com ]